1. INS Vascular Access Device (VAD) Selection Algorithm
The 9th Edition of the INS Standards of Practice enforces a patient-centered Vascular Access Device (VAD) selection algorithm designed to preserve vascular real estate and prevent catheter-related venous thrombosis:
VAD Selection Hierarchy:
- Peripheral Intravenous Catheters (PIVC): Indicated for continuous or intermittent infusions anticipated for ≤5 to 7 days, with solutions meeting physiological peripheral compatibility parameters.
- Midline Catheters (1.5 to 8 inches dwell): Indicated for expected infusion durations of 6 to 14 days. Catheter tip terminates in the basilic, cephalic, or brachial vein at or below the axillary line. Strict limitation: Midlines are peripheral lines; vesicants, solutions >900 mOsm/L, and extreme pH agents are strictly forbidden.
- Peripherally Inserted Central Catheters (PICC): Indicated for therapy durations exceeding 14 days, or for any duration requiring vesicant chemotherapy, hyperosmolar solutions (>900 mOsm/L), or high-irritant antibiotics. Tip must terminate at the cavoatrial junction.
2. Standard 26: The ≤45% Catheter-to-Vein Ratio Rule
INS Standard 26 mandates that the external diameter of a vascular access catheter must occupy 45% or less of the internal vein lumen diameter under ultrasound measurement:
When a catheter exceeds 45% of vein lumen, blood velocity around the catheter plummets. Stagnant blood flow induces endothelial shear stress, platelet deposition, and a 4-fold higher incidence of symptomatic deep vein thrombosis (DVT) and catheter-related phlebitis.
3. Standard 41: Osmolarity Thresholds & DIVA Ultrasound Guidance
INS Standard 41 strictly delineates vascular selection based on solution osmolarity and pH:
Standard 41 Osmolarity & pH Thresholds:
- Peripheral Safe Zone (<600 mOsm/L): Suitable for short peripheral and midline catheters.
- Intermediate Risk Zone (600 to 900 mOsm/L): Caution zone; associated with escalating chemical thrombophlebitis. Midline or short-term central line recommended.
- Central Access Mandatory (>900 mOsm/L): Parenteral solutions with osmolarity exceeding 900 mOsm/L (e.g., TPN with >12.5% dextrose, hypertonic saline, concentrated electrolytes) or extreme pH (<5.0 or >9.0) must be infused exclusively into central veins terminating in the superior vena cava.
For patients meeting Difficult Vascular Access (DIVA) criteria, standard 28 mandates real-time ultrasound guidance after no more than two failed blind cannulation attempts.